US20030199538A1 - Pharmaceutical formulation comprising an immune response modifier - Google Patents

Pharmaceutical formulation comprising an immune response modifier Download PDF

Info

Publication number
US20030199538A1
US20030199538A1 US10/306,019 US30601902A US2003199538A1 US 20030199538 A1 US20030199538 A1 US 20030199538A1 US 30601902 A US30601902 A US 30601902A US 2003199538 A1 US2003199538 A1 US 2003199538A1
Authority
US
United States
Prior art keywords
imidazo
1h
amine
formulation
quinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/306,019
Inventor
Raymond Skwierczynski
Terri Busch
Amy Gust-Heiting
Mary Fretland
Matthew Scholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US34060501P priority Critical
Priority to US37845202P priority
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Priority to US10/306,019 priority patent/US20030199538A1/en
Assigned to 3M INNOVATIVE PROPERTIES COMPANY reassignment 3M INNOVATIVE PROPERTIES COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BUSCH, TERRI F., FRETLAND, MARY, GUST-HEITING, AMY L., SCHOLZ, MATTHEW T., SKWIERCZYNSKI, RAYMOND D.
Publication of US20030199538A1 publication Critical patent/US20030199538A1/en
Application status is Abandoned legal-status Critical

Links